Viewing Study NCT01413503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2026-07-12 @ 4:17 PM
Study NCT ID: NCT01413503
Status: COMPLETED
Last Update Posted: 2018-09-18
First Post: 2011-08-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
Sponsor: University of California, San Francisco
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pheochromocytoma View
None Paraganglioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pheochromocytoma View
None Paraganglioma View
None MIBG View
None 131I-MIBG View
None Resistant View
None Relapsed View
None Treatment View
None UCSF View
None Pediatric View
None Adult View
None Oncology View